<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Juvet SC</submitter><funding>Canadian Institutes of Health Research</funding><pagination>e47732</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3471870</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(10)</volume><pubmed_abstract>TCRαβ(+) CD4(-)CD8(-)NK(-) double negative T cells (DN T cells) can act as regulatory T cells to inhibit allograft rejection and autoimmunity. Their role in graft-versus-host disease and mechanisms of suppression remain elusive. In this study, we demonstrate that DN T cells can inhibit CD4(+) T cell-mediated GVHD in a semi-allogeneic model of bone marrow transplantation. Furthermore, we present evidence of a novel autocrine IFNγ signaling pathway in Fas-deficient C57BL/6.lpr (B6.lpr) DN T cells. B6.lpr DN T cells lacking IFNγ or its receptor were impaired in their ability to suppress syngeneic CD4(+) T cells responding to alloantigen stimulation both in vitro and in vivo. Autocrine IFNγ signaling was required for sustained B6.lpr DN T cell IFNγ secretion in vivo and for upregulation of surface Fas ligand expression during TCR stimulation. Fas ligand (FasL) expression by B6.lpr DN T cells permitted lysis of activated CD4(+) T cells and was required for suppression of GVHD. Collectively, our data indicate that DN T cells can inhibit GVHD and that IFNγ plays a critical autocrine role in controlling the regulatory function of B6.lpr DN T cells.</pubmed_abstract><journal>PloS one</journal><pubmed_title>Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.</pubmed_title><pmcid>PMC3471870</pmcid><funding_grant_id>14431</funding_grant_id><pubmed_authors>Kim EY</pubmed_authors><pubmed_authors>Adeyi O</pubmed_authors><pubmed_authors>Vanama R</pubmed_authors><pubmed_authors>Joe B</pubmed_authors><pubmed_authors>Jeon C</pubmed_authors><pubmed_authors>Juvet SC</pubmed_authors><pubmed_authors>Han M</pubmed_authors><pubmed_authors>Zhao FL</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.</name><description>TCRαβ(+) CD4(-)CD8(-)NK(-) double negative T cells (DN T cells) can act as regulatory T cells to inhibit allograft rejection and autoimmunity. Their role in graft-versus-host disease and mechanisms of suppression remain elusive. In this study, we demonstrate that DN T cells can inhibit CD4(+) T cell-mediated GVHD in a semi-allogeneic model of bone marrow transplantation. Furthermore, we present evidence of a novel autocrine IFNγ signaling pathway in Fas-deficient C57BL/6.lpr (B6.lpr) DN T cells. B6.lpr DN T cells lacking IFNγ or its receptor were impaired in their ability to suppress syngeneic CD4(+) T cells responding to alloantigen stimulation both in vitro and in vivo. Autocrine IFNγ signaling was required for sustained B6.lpr DN T cell IFNγ secretion in vivo and for upregulation of surface Fas ligand expression during TCR stimulation. Fas ligand (FasL) expression by B6.lpr DN T cells permitted lysis of activated CD4(+) T cells and was required for suppression of GVHD. Collectively, our data indicate that DN T cells can inhibit GVHD and that IFNγ plays a critical autocrine role in controlling the regulatory function of B6.lpr DN T cells.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2025-07-03T03:04:53.843Z</modification><creation>2025-07-03T03:04:53.843Z</creation></dates><accession>S-EPMC3471870</accession><cross_references><pubmed>23077665</pubmed><doi>10.1371/journal.pone.0047732</doi></cross_references></HashMap>